These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36631277)

  • 1. Toward Personalized Nanomedicine: The Critical Evaluation of Micro and Nanodevices for Cancer Biomarker Analysis in Liquid Biopsy.
    Clack K; Soda N; Kasetsirikul S; Mahmudunnabi RG; Nguyen NT; Shiddiky MJA
    Small; 2023 Apr; 19(15):e2205856. PubMed ID: 36631277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Nanotechnologies for Liquid Biopsy: The Detection of Circulating Tumor Cells and Extracellular Vesicles.
    Li W; Wang H; Zhao Z; Gao H; Liu C; Zhu L; Wang C; Yang Y
    Adv Mater; 2019 Nov; 31(45):e1805344. PubMed ID: 30589111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced liquid biopsy technologies for circulating biomarker detection.
    Soda N; Rehm BHA; Sonar P; Nguyen NT; Shiddiky MJA
    J Mater Chem B; 2019 Nov; 7(43):6670-6704. PubMed ID: 31646316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Status quo of Extracellular Vesicle isolation and detection methods for clinical utility.
    Visan KS; Wu LY; Voss S; Wuethrich A; Möller A
    Semin Cancer Biol; 2023 Jan; 88():157-171. PubMed ID: 36581020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Liquid Biopsy Using Integrated Microfluidic Exosome Analysis Platforms.
    Li G; Tang W; Yang F
    Biotechnol J; 2020 May; 15(5):e1900225. PubMed ID: 32032977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refining Cancer Management Using Integrated Liquid Biopsy.
    Qiu J; Xu J; Zhang K; Gu W; Nie L; Wang G; Luo Y
    Theranostics; 2020; 10(5):2374-2384. PubMed ID: 32089746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid biopsy, a paradigm shift in oncology: what interventional radiologists should know.
    Calandri M; Siravegna G; Yevich SM; Stranieri G; Gazzera C; Kopetz S; Fonio P; Gupta S; Bardelli A; Veltri A; Odisio BC
    Eur Radiol; 2020 Aug; 30(8):4496-4503. PubMed ID: 32193642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging on-chip electrokinetic based technologies for purification of circulating cancer biomarkers towards liquid biopsy: A review.
    Shi L; Esfandiari L
    Electrophoresis; 2022 Jan; 43(1-2):288-308. PubMed ID: 34791687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in liquid biopsy on-chip for cancer management: Technologies, biomarkers, and clinical analysis.
    Tadimety A; Closson A; Li C; Yi S; Shen T; Zhang JXJ
    Crit Rev Clin Lab Sci; 2018 May; 55(3):140-162. PubMed ID: 29388456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial Biomarkers in Liquid Biopsy for Cancer: An Overview and Future Directions.
    Luo F; Wang X; Ye C; Sun H
    Cancer Control; 2024; 31():10732748241292019. PubMed ID: 39431347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microfluidics-Based Urine Biopsy for Cancer Diagnosis: Recent Advances and Future Trends.
    Wang Y; Gao Y; Song Y
    ChemMedChem; 2022 Oct; 17(20):e202200422. PubMed ID: 36040297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid biopsy: the value of different bodily fluids.
    Santos V; Freitas C; Fernandes MG; Sousa C; Reboredo C; Cruz-Martins N; Mosquera J; Hespanhol V; Campelo R
    Biomark Med; 2022 Feb; 16(2):127-145. PubMed ID: 35073730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-Sensitive and Selective Electrochemical Bio-Fluid Biopsy for Oral Cancer Screening.
    Xiao Z; Huang C; Jiang S; Kong X; Teng Y; Niu B; Zhu C; Xin W; Chen X; Wen L; Wei Y; Deng X
    Small Methods; 2021 May; 5(5):e2001205. PubMed ID: 34928075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in Exosomal Protein Detection Via Liquid Biopsy Biosensors for Cancer Screening, Diagnosis, and Prognosis.
    Liu C; Yang Y; Wu Y
    AAPS J; 2018 Mar; 20(2):41. PubMed ID: 29520676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid biopsy for early diagnosis of non-small cell lung carcinoma: recent research and detection technologies.
    Chang L; Li J; Zhang R
    Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188729. PubMed ID: 35436521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid Biopsy as a Tool for the Diagnosis, Treatment, and Monitoring of Breast Cancer.
    Freitas AJA; Causin RL; Varuzza MB; Calfa S; Hidalgo Filho CMT; Komoto TT; Souza CP; Marques MMC
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnology Strategies for the Analysis of Circulating Tumor DNA: A Review.
    Chen X; Wang L; Lou J
    Med Sci Monit; 2020 Mar; 26():e921040. PubMed ID: 32200389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in point-of-care diagnostic devices in cancers.
    Sandbhor Gaikwad P; Banerjee R
    Analyst; 2018 Mar; 143(6):1326-1348. PubMed ID: 29469148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid biopsy in the clinical management of bladder cancer: current status and future developments.
    Kouba E; Lopez-Beltran A; Montironi R; Massari F; Huang K; Santoni M; Chovanec M; Cheng M; Scarpelli M; Zhang J; Cimadamore A; Cheng L
    Expert Rev Mol Diagn; 2020 Feb; 20(2):255-264. PubMed ID: 31608720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.